Remove Conditions Remove Events Remove Extraction Remove Pharmaceutical
article thumbnail

Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in Its Montmagny Facility

Cannabis Law Report

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

article thumbnail

Curaleaf International Advances Accessibility of Medical Cannabis Products in Germany with Strategic Partnership

Cannabis Law Report

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

PAOG Cites New British Medical Journal Case Report On CBD Lung Cancer And COPD Treatment As Validation Of PAOG Ongoing RespRx Drug Research

Cannabis Law Report

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. The ongoing research targets the treatment of respiratory disorders in support of a pharmaceutical being developed by PAOG under the name RespRx. 9,199,960).

article thumbnail

Agrify Acquires Lab Society

Cannabis Law Report

Lab Society is a Leader in Distillation and Solvent Separation Solutions for the Cannabis Extraction Industry with $10 Million in Annual Revenue. Acquisition Further Solidifies Agrify as the Largest and Most Comprehensive Provider of High- Quality Extraction Solutions for the Cannabis and Hemp Industry Globally. BILLERICA, Mass.,

article thumbnail

ZYUS Life Sciences Launches New Medical Cannabinoid Formulation for Direct to Patient Sales in Canada

Cannabis Law Report

ZYUS refines its cannabinoid extracts in an industry leading, pharmaceutical-grade extraction facility using raw material exclusively from licensed producers regulated by Health Canada. ZYUS’ ethanol-based technology is used to achieve superior extraction efficiency while ensuring a high product quality and long shelf life.

article thumbnail

Mary AG Now Has Room to Grow Hemp in China Through CBDer Partnership

Cannabis Law Report

This partnership marks Mary AG’s first application of farm-level technology, taking its knowledge in automated systems and applying that expertise to a holistic, controlled growing condition that incorporates automated plant health assessment. Working with CBDer on potential non-China greenhouse projects.

Hemp 105
article thumbnail

Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

Cannabis Law Report

“This is a landmark event for Gb Sciences,” said Chairman and CEO John Poss. and 43 international patent-pending applications, which provide patent protection for both PhAROS™, its proprietary drug discovery engine, and its novel, plant-inspired combination drugs for the treatment of more than 65 serious medical conditions.